These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36297577)

  • 21. Matrix Metalloproteinases and Glaucoma Treatment.
    Weinreb RN; Robinson MR; Dibas M; Stamer WD
    J Ocul Pharmacol Ther; 2020 May; 36(4):208-228. PubMed ID: 32233938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma.
    Peace JH; McKee HJ; Kopczynski CC
    Ophthalmol Ther; 2021 Mar; 10(1):89-100. PubMed ID: 33244711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension.
    Fingeret M; Gaddie IB; Bloomenstein M
    Clin Exp Optom; 2019 Nov; 102(6):541-550. PubMed ID: 30614563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma.
    Jayanetti V; Sandhu S; Lusthaus JA
    J Exp Pharmacol; 2020; 12():539-548. PubMed ID: 33244278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension.
    Katsanos A; Riva I; Bozkurt B; Holló G; Quaranta L; Oddone F; Irkec M; Dutton GN; Konstas AG
    Expert Opin Drug Saf; 2022 Apr; 21(4):525-539. PubMed ID: 34666576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension.
    Tamçelik N; Izgi B; Temel A; Yildirim N; Okka M; Özcan A; Yüksel N; Elgin U; Altan Ç; Ozer B
    Clin Ophthalmol; 2017; 11():723-731. PubMed ID: 28458511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Senescent phenotype of trabecular meshwork cells displays biomarkers in primary open-angle glaucoma.
    Babizhayev MA; Yegorov YE
    Curr Mol Med; 2011 Oct; 11(7):528-52. PubMed ID: 21707516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological profiles of latanoprost (Xalatan), a novel anti-glaucoma drug].
    Nomura S; Hashimoto M
    Nihon Yakurigaku Zasshi; 2000 May; 115(5):280-6. PubMed ID: 10872179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension.
    Matsuo M; Matsuoka Y; Tanito M
    Clin Ophthalmol; 2022; 16():1261-1279. PubMed ID: 35510270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study.
    Sit AJ; Gupta D; Kazemi A; McKee H; Challa P; Liu KC; Lopez J; Kopczynski C; Heah T
    Am J Ophthalmol; 2021 Jun; 226():262-269. PubMed ID: 33524367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension.
    Iester M
    Clin Ophthalmol; 2008 Sep; 2(3):517-23. PubMed ID: 19668749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews.
    Daka Q; Trkulja V
    Croat Med J; 2014 Oct; 55(5):468-80. PubMed ID: 25358880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis.
    Harasymowycz P; Hutnik C; Rouland JF; Negrete FJM; Economou MA; Denis P; Baudouin C
    Adv Ther; 2021 Jun; 38(6):3019-3031. PubMed ID: 33891269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy.
    Fung DS; Whitson JT
    Clin Ophthalmol; 2014; 8():543-54. PubMed ID: 24648719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Relationship of Intraocular Pressure and Anterior Chamber Volume With Use of Prostaglandin Analogues.
    Scott JA; Roberts CJ; Mahmoud AM; Jain SG
    J Glaucoma; 2021 May; 30(5):421-427. PubMed ID: 33149104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: A prospective, open-label, randomized, two-arm, parallel-group study.
    Vetrugno M; Cardascia N; Cantatore F; Sborgia C
    Curr Ther Res Clin Exp; 2004 Nov; 65(6):444-54. PubMed ID: 24672097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of prostaglandin analogues on aqueous humor outflow pathways.
    Winkler NS; Fautsch MP
    J Ocul Pharmacol Ther; 2014; 30(2-3):102-9. PubMed ID: 24359106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.